The Global Anxiety Disorders & Depression Treatment Market is projected to reach approximately US$ 37.3 billion by 2035, rising from US$ 22.7 billion in 2025, at a CAGR of 5.1% during the forecast period from 2026 to 2035. In 2025, North America dominated the global market, accounting for more than 64.2% of the total market share and generating around US$ 10.5 billion in revenue.